Skip to content
DataLookout
Menu

NCT07933640

A Clinical Study on Vagus Nerve Blockade at the Gastroesophageal Junction Combined With Tegileridine in the Very Early Postoperative Recovery Following Bariatric Surgery

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Visual analogue scale (VAS) Score
Timeframe: postoperative 0, 2, 6, 12, and 24 hours

Secondary (7)

Quality-of-Recovery 15 (QoR-15) Score
Incidence of postoperative respiratory depression
Rescue analgesia rate
Total dose of sufentanil for rescue analgesia
Time of first ambulation
Show 2 moreShow less
Total Hospital Stay
Adverse effects

Arms and interventions

The control groupActive comparator

Bilateral transverse abdominal plane block and intravenous administration of Tegileridine

The experimental groupExperimental

Bilateral transverse abdominal plane block and intravenous administration of Tegileridine combined with the vagus nerve block at the gastroesophageal junction

Procedures: Bilateral transverse abdominal plane block and intravenous administration of Tegileridine combined with the vagus nerve block at the gastroesophageal junction, Bilateral Transversus Abdominis Plane Block (TAPB) and Intravenous infusion of Tegileridine.